Objective/purpose
=================

Induction of IDO in dendritic cells (DCs) depletes the essential amino acid, tryptophan, and generates a family of catabolites known as kynurenines (KYN). IDO activity is reported to have immunomodulatory effects, including the selective induction of apoptosis in T-helper 1 (Th1) lymphocytes, an effect not seen with Th2 cells that are dominant in allergic asthma. Infants hospitalized for RSV-related bronchiolitis have increased risk of developing asthma (48% vs. 8% in control). Induction of IDO activity by RSV may explain the link between RSV bronchiolitis and asthma pathogenesis. IDO is induced by various cytokines and a number of non-airway viruses; however, RSV has not yet been studied. We hypothesize that RSV induce IDO activation in human dendritic cells (DCs).

Methods
=======

Primary human dendritic cells (DCs) were infected with sucrose gradient purified RSV with a multiplicity of infection (MOI) rate of 1.0. Flow cytometry and confocal microscopy were used to confirm infection. We measured KYN in culture media by a spectrophotometric method using Ehrlich reagent. We blocked RSV infection with the RSV-mAb, Palivizumab, and UV-inactivation to determine a role for infection. The potent competitive inhibitor of viral RNA polymerase, Ribavirin, was used to block RSV replication and protein synthesis. To evaluate dependency of RSV-induced IDO induction on different cell signaling pathways, we used a variety of specific inhibitors including MEK inhibitor I (120 nM), MEK inhibitor II (4 μM), SB202190 (p38-MAPK, 3 μM), JNK inhibitor II (1 μM), IKK inhibitor II (Wedelolactone, 30 μM), IKK inhibitor III (BMS-345541, 3 μM) and relevant negative controls.

Findings
========

DCs incubated with RSV showed a 35% shift in flow cytometry compared to uninfected control DCs (n = 12) thus confirming infection of DCs. KYN, as a marker of IDO induction, was increased 13.2 fold in supernatants of infected DCs compared with control DCs (43.6 vs. 3.3 μM, n = 6). Inactivation of virus by Palivizumab or UV resulted in 99% decrease in levels of KYN compared to controls (n = 3). Infecting DCs with higher MOI of UV-inactivated RSV (up to 20, n = 3) did not induce IDO. Addition of Ribavirin to culture media reduced KYN release in a dose-dependent manner with 50% reduction at 220 μM (n = 3), without having any blocking effect on positive controls (IFN-γ induced KYN release) at similar concentrations. Except for SB202190, none of the specific inhibitors of signaling pathway including NF-κB, JNK-MAPK and MEK/ERK-MAPK showed any significant inhibitory effect on IDO induction by RSV (n = 3). SB202190, the specific inhibitor of P38-MAPK, blocked 51% (IC~50~= 300 nM) and 92% (3 μM) of KYN release (n = 3); negative controls showed no inhibitory effect.

Deliverables
============

Our data showing IDO to be induced in DCs following infection with RSV is novel. Further, the observation that induction was dependent on viral replication was unexpected. Although NF-κB is reported to have a role in IDO induction, our data suggest that RSV-induced kynurenine release may occur through an NF-κB-independent pathway.

Relevance
=========

These data support our hypothesis that RSV plays a role in the development of an immune response towards a Th2 pattern. Prevention of RSV infection could decrease the incidence of asthma. We expect to be publishing these novel findings in 2010.
